Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biotechnology Letters is Scopus-indexed (Q2, CiteScore 4.5), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer Science and Business Media B.V..
Checked against the index lists dated .
ISSN 0141-5492Verify ISSN ↗1573-6776Verify ISSN ↗
Publisher: Springer Science and Business Media B.V.
Cost to publish: About US$3,890 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biotechnology | 159 / 325 | 51st | Q2 |
| Applied Microbiology and Biotechnology | 71 / 134 | 47th | Q3 |
| Bioengineering | 106 / 168 | 37th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1979–present, best quartile Q2, CiteScore 4.5.
Biotechnology Letters is Q2 in Biotechnology (rank 159 of 325), Q3 in Applied Microbiology and Biotechnology (rank 71 of 134) and Q3 in Bioengineering (rank 106 of 168), by CiteScore 2025.
Biotechnology Letters is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.5, which places it in quartile Q2 at the 51st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.594, quartile Q2, with an H-index of 138.
The publisher lists an article processing charge of about US$3,890 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Biotechnology Letters is published by Springer Science and Business Media B.V. Its print ISSN is 0141-5492 and its online ISSN is 1573-6776.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Biotechnology Letters has an h-index of 151 and a 2-year mean of 2.21 citations per paper (OpenAlex). Its Scopus CiteScore is 4.5, quartile Q2. On 2-year citations it ranks #165 of 309 Scopus journals in Biotechnology.
Biotechnology Letters published 130 papers in 2025; its busiest recent year was 2020 with 262. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from China (28.8%), India (18.5%) and Iran (7.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 21 retracted papers are recorded (1.8 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.